Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
Since diabetes is a global epidemic, the development of novel therapeutic strategies for the treatment of this disease is of major clinical interest. Diabetes is differentiated in two types: type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). T1DM arises from an autoimmune destructi...
Main Authors: | Emmanuel Ampofo, Lisa Nalbach, Michael D. Menger, Mathias Montenarh, Claudia Götz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/18/4398 |
Similar Items
-
Protein Kinase CK2 Controls Ca<sub>V</sub>2.1-Dependent Calcium Currents and Insulin Release in Pancreatic β-Cells
by: Rebecca Scheuer, et al.
Published: (2020-06-01) -
Protein Kinase CK2 Regulates Nerve/Glial Antigen (NG)2-Mediated Angiogenic Activity of Human Pericytes
by: Beate M. Schmitt, et al.
Published: (2020-06-01) -
Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma
by: Ampofo, E., et al.
Published: (2022) -
The Phosphorylation of PDX-1 by Protein Kinase CK2 Is Crucial for Its Stability
by: Sabrina Klein, et al.
Published: (2016-12-01) -
Targeting Casein Kinase 1 (CK1) in Hematological Cancers
by: Pavlína Janovská, et al.
Published: (2020-11-01)